Influence on survival of early diagnosis of breast cancer by breast screening: Results of a longitudinal study 1981-1990;Fortschritte in der früherkennung des mammakarzinoms in den jahren 1981 - 1990: Ergebnisse einer longitudinalstudie

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 12, 2003, Pages 601-606

  Janni, Wolfgang ^a   Sommer, H ^a   Strobl, B ^a   Rack, B ^a   Klanner, E ^a   Hantschmann, P ^a   Rammel, G ^a   Harms, G ^a   Dimpfl, T ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b KLINIKUM KASSEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GERMANY; HUMANS; LONGITUDINAL STUDIES; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 0037459525     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38054     Document Type: Article

References (34)

1. Alexander FE, Anderson TJ, Brown HK et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999; 353: 1903-1908
2. Altmann U, Katz FR, Tafazzoli AG, Haeberlin V, Dudeck J. GTDS - a tool for tumor registries to support shared patient care. Proc AMIA Annu Fall Symp 1996: 512-516
3. Andersson I, Aspegren K, Janzon L et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988; 297: 943-948
4. Bahnsen J. Bedeutung der Mammographie für die Brustkrebs-Vorsorgeuntersuchung. (Significance of mammography for preventive screening of breast cancer). Gynäkologe 1987; 20: 243-253
5. Bjurstam N, Bjorneld L, Duffy SW et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 1997; 80: 2091-2099
6. Blichert TM, Rose C, Andersen JA et al. Danish Breast Cancer Cooperative Group. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr 1992; 11: 19-25
7. Bonneux L. Update on effects of screening mammography - letter to the editor. Lancet 2002; 360: 338
8. Bottcher HD. Zur Strahlentherapie bei Mamma-Karzinom (Radiation therapy in breast carcinoma). Zentralbl Gynakol 1991; 113: 1147-1161
9. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181-187
10. Cheng KK. Update on effects of screening mammography - letter to the editor. Lancet 2002; 360: 339
11. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 1988; 80: 1125-1132
12. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220
13. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Followup after 11 years - update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997; 45: 263-270
14. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights. International Consensus Panel on the Treatment of Primary Breast Cancer: Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001; 19: 3817-3827
15. Goldhirsch A, Glick JH, Gelber RD, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst 1998; 90: 1601-1608
16. Gotzsche PC. Update on effects of screening mammography - letter to the editor. Lancet 2002; 360: 338
17. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355: 129-134
18. Gulbrandsen P, Update on effects of screening mammography - letter to the editor. Lancet 2002; 360: 339
19. Halsted WS. The results of radical operation for the cure of carcinoma of the breast. Ann Surg 1907; 46: 1-19
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481
21. Kubista E, Kucera H. Vorsorgemedizin beim Mammakarzinom (Preventive medicine in breast neoplasms). Gynakol Rundsch 1980; 20: 110-116
22. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study: update on breast cancer mortality. J Natl Cancer Inst Monogr 1997; 22: 37-41
23. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000; 92: 1490-1499
24. Nystrom L, Andersson I, Bjurstam N, Frisell J, Rutqvist LE. Update on effects of screening mammography - authors reply to letters to the editor. Lancet 2002; 360: 340
25. Nystrom L, Rutqvist LE, Wall S et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 973-978
26. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358: 1340-1342
27. Olsen O, Gotzsche PC. Screening for breast cancer with mammography, Cochrane Database Syst Rev 2001: CD001877
28. Scherer E, Seifert J. Die Bedeutung der Mammographie als Reihenuntersuchung in der Tumorvorsorge. Erste Ergebnisse an 1080 untersuchten Frauen (Significance of mammography as a mass-screening technic in tumor detection. 1st results in 1080 examined women). Fortschr Geb Roentgenstr Nuklearmed 1968; 109: 766-770
29. Sobin LH. Frequently asked questions regarding the application of the TNM classification. TNM/Prognostic Factors Project (International Union Against Cancer [UICC]). Cancer 1999; 85: 1405-1406
30. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-1804
31. Strasser E. Sind Vorsorgeuntersuchungen auf Brustkrebs sinnvoll? (Is breast cancer screening effective?). Wien Med Wochenschr 1979; 129: 653-655
32. Tabar L, Fagerberg G, Chen HH et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 1995; 75: 2507-2517
33. Tabar L, Smith RA, Duffy SW. Update on effects of screening mammography - letter to the editor. Lancet 2002; 360: 337
34. Wenderlein JM. Brust-Vorsorge-Untersuchungen ab 30. Lebensjahr? Grund zu Skepsis oder Optimismus (Breast screening from the 30th year of life? Reason for skepticism or optimism). MMW Munch Med Wochenschr 1983; 125: 697-699